Can GLP-1 analogues cure obesity or type 2 diabetes
POS has been proposed as a probable mechanism contributing to systemic OxS, T2D progression, and vascular damage (see Figure 3) [91,92]
Monitoring Progress and Adjusting Your GLP-1 Treatment Plan Effective monitoring is essential to assess treatment response, identify potential complications, and optimise outcomes with GLP-1 receptor agonist therapy
Lunch: 10 Meals You Can Make at Work or Home #11
Hormonal therapies are the first choice, before surgery and after surgery, in order to reduce the risk of recurrence
This was demonstrated in two randomised controlled trials (RCTs) that showed a decrease in epicardial adipose tissue in patients with T2D and obesity on liraglutide and exenatide according to echocardiography and cardiac MRI